Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]
News [6469]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
Somatic mutation profile of breast cancer in Uganda
Dr Manoj Menon - Fred Hutchinson Cancer Center, Seattle, USA
Somatic mutation profile of breast cancer in Uganda ( Dr Manoj Menon - Fred Hutchinson Cancer Center, Seattle, USA )
8 Jun 2023
Talazoparib plus enzalutamide shows improvement in PFS over standard of care in...
Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France
Talazoparib plus enzalutamide shows improvement in PFS over standard of care in firstline HRR mCRPC ( Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France )
6 Jun 2023
CDK4/6 inhibitors added to first line show no greater benefit when compared to...
Dr Gabe Sonke - Netherlands Cancer Institute, Amsterdam, Netherlands
CDK4/6 inhibitors added to first line show no greater benefit when compared to their use in second line therapy in HR+, HER2- ABC ( Dr Gabe Sonke - Netherlands Cancer Institute, Amsterdam, Netherlands )
6 Jun 2023
Prognostic value of HER2-low status in breast cancer: A systematic review and...
Dr Chiara Molinelli - Università degli Studi di Genova, Genoa, Italy
Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis ( Dr Chiara Molinelli - Università degli Studi di Genova, Genoa, Italy )
6 Jun 2023
Baseline liquid biopsy results in treatment efficacy of FOLFIRI/cetuximab in...
Prof Sebastian Stintzing - Universitätsmedizin Berlin, Berlin, Germany
Baseline liquid biopsy results in treatment efficacy of FOLFIRI/cetuximab in patients with tissue RAS-WT mCRC ( Prof Sebastian Stintzing - Universitätsmedizin Berlin, Berlin, Germany )
4 Jun 2023
AI-derived digital pathology-based biomarker predicts benefit of long-term ADT...
Prof Andrew Armstrong - Duke University, Durham, USA
AI-derived digital pathology-based biomarker predicts benefit of long-term ADT with RT in localised high-risk prostate cancer ( Prof Andrew Armstrong - Duke University, Durham, USA )
3 Jun 2023
Choosing cancer medicines wisely in Africa
Dr Harrison Chuwa - Aga Khan Hospital, Dar es Salaam, Tanzania
Choosing cancer medicines wisely in Africa ( Dr Harrison Chuwa - Aga Khan Hospital, Dar es Salaam, Tanzania )
18 May 2023
Choosing Wisely in pathology
Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in pathology ( Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
18 May 2023
Choosing Wisely in radiology Tanzania
Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
18 May 2023
Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes...
Dr Joshua Choe - Columbia University, New York City, USA
Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death ( Dr Joshua Choe - Columbia University, New York City, USA )
27 Apr 2023
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
26 Apr 2023
Why tumour markers are NOT recommended as screening tests
Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
Why tumour markers are NOT recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
25 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation